Sutro Biopharma (STRO) Net Cash Flow Growth (3y) (2020 - 2025)
Sutro Biopharma (STRO) Net Cash Flow Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Sutro Biopharma | 192.86 Mn | 51.43 Mn | - | 46.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.00% |
| Sep 30, 2025 | -52.43% |
| Jun 30, 2025 | -41.62% |
| Mar 31, 2025 | -281.60% |
| Dec 31, 2024 | 281.84% |
| Sep 30, 2024 | 73.94% |
| Jun 30, 2024 | 254.49% |
| Mar 31, 2024 | 69.99% |
| Dec 31, 2023 | -27.83% |
| Sep 30, 2023 | -981.97% |
| Jun 30, 2023 | 99.37% |
| Mar 31, 2023 | -26.68% |
| Dec 31, 2022 | -92.03% |
| Sep 30, 2022 | 63.56% |
| Jun 30, 2022 | 107.62% |
| Mar 31, 2022 | 75.16% |
| Dec 31, 2021 | -26.07% |
| Sep 30, 2021 | -53.43% |
| Jun 30, 2021 | -68.74% |
| Mar 31, 2021 | -113.78% |